US 7629336
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7629336 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P37/08